Introduction
KLOR-CON® is a brand of potassium chloride extended-release tablets, used primarily for the treatment and prevention of hypokalemia. Here, we will delve into the market analysis and price projections for this specific drug, identified by the NDC code 0245-5316.
Market Context
The pharmaceutical market, particularly for prescription drugs, is subject to various factors that influence pricing and demand. Here are some key points to consider:
Price Increases in Prescription Drugs
Historically, prescription drug prices tend to increase significantly in January and July each year. In 2022, the average price increase in January was nearly $150 per drug (10% increase), and in July, it was $250 (7.8% increase)[2].
Pharmacy Market Outlook
For 2025, the pharmacy market is expected to see stable overall drug price inflation, with a projected rate of 0.00% for the period from January 1, 2025, to December 31, 2025, according to Vizient's Pharmacy Market Outlook[3].
Specific Drug Analysis: KLOR-CON® (NDC: 0245-5316)
Drug Description
KLOR-CON® extended-release tablets, with the NDC code 0245-5316, contain 750 mg of microencapsulated potassium chloride, equivalent to 10 mEq of potassium. These tablets are designed for oral use and are indicated for the treatment of patients with hypokalemia and for the prevention of hypokalemia in high-risk patients[1][4].
Pricing Trends
Given the general trend of prescription drug price increases, it is likely that KLOR-CON® will experience some level of price adjustment. However, the extent of this increase is subject to various factors, including market competition, regulatory changes, and the overall economic environment.
Historical Price Increases
In recent years, the number of prescription drug price increases has been significant, especially in January and July. While the specific price changes for KLOR-CON® are not detailed in the available sources, it is reasonable to expect that this drug could follow similar trends. For instance, in 2022, over 3000 drugs experienced price increases in January alone[2].
Projected Price Stability for 2025
Despite the historical trend of price increases, the Vizient Pharmacy Market Outlook suggests a stable pricing environment for 2025, which might mitigate significant price hikes for KLOR-CON® and other drugs[3].
Factors Influencing Pricing
Several factors can influence the pricing of KLOR-CON®:
Regulatory Environment
Changes in regulatory policies, such as those related to Medicare Part B pricing, can impact the pricing of prescription drugs. The Centers for Medicare and Medicaid Services (CMS) plays a crucial role in determining payment limits and pricing for drugs, including those used under Medicare Part B[5].
Market Competition
The presence of generic or alternative potassium chloride products can influence the pricing of KLOR-CON®. Market competition often drives prices down or stabilizes them.
Economic Conditions
General inflation rates and economic conditions can also affect drug pricing. For example, in 2022, the Consumer Price Index (CPI) increased by 8.5%, which was slightly higher than the average July price increase for prescription drugs[2].
Precautions and Usage Considerations
While pricing is a critical aspect, it is also important to consider the clinical use and precautions associated with KLOR-CON®. The drug should be used cautiously, especially in patients with impaired renal function or those who are elderly, due to the risk of toxic reactions[1][4].
Key Takeaways
- Pricing Trends: Expect potential price increases, especially in January and July, but with a stable overall inflation rate projected for 2025.
- Regulatory Environment: CMS policies and Medicare Part B pricing can impact the drug's pricing.
- Market Competition: Presence of generic or alternative products can stabilize or reduce prices.
- Economic Conditions: General inflation and economic factors influence pricing decisions.
- Clinical Use: Caution is advised in patients with impaired renal function or elderly patients.
FAQs
Q: What is the typical dosage for KLOR-CON® extended-release tablets?
A: The dosage must be adjusted to the individual needs of each patient, with dosages greater than 40 mEq per day divided into multiple doses[4].
Q: What are the common side effects of KLOR-CON®?
A: Severe vomiting, abdominal pain, distention, or gastrointestinal bleeding are potential side effects that necessitate immediate discontinuation of the drug[1].
Q: How does the regulatory environment affect the pricing of KLOR-CON®?
A: CMS policies and Medicare Part B pricing guidelines can influence the payment limits and pricing for the drug[5].
Q: What is the projected price inflation rate for prescription drugs in 2025?
A: The projected overall drug price inflation rate for 2025 is 0.00% according to Vizient's Pharmacy Market Outlook[3].
Q: Why are January and July significant months for prescription drug price increases?
A: Historically, most prescription drug price increases occur in January and July, with January seeing the largest number of increases[2].
Cited Sources
- DailyMed: KLOR-CON M- potassium chloride tablet, extended release.
- ASPE: Price Increases for Prescription Drugs, 2016-2022.
- Vizient Inc.: Pharmacy Market Outlook Summer 2024.
- DailyMed: KLOR-CON- potassium chloride tablet, film coated, extended release.
- CMS: ASP Pricing Files.
